Archives

by in
Entry Author Date Location
ZymoGenetics Trial Halted, Amgen’s Big New Drug, Spiration Gets FDA Nod, & More Seattle-Area Life Sciences News 10/30/08 Seattle
Amgen Scientist, After 13-Year Push, Sees Bone Cancer Work Paying Dividends 10/29/08 Seattle
Amgen’s Dmab Cuts Fracture Risk for Osteoporosis Patients, Just What Investors Wanted to See 09/16/08 Seattle
Amgen Osteoporosis Drug Reduces Bone Fractures in Pivotal Study 07/25/08 Seattle
Page 2 of 2 « previous page